The longitudinal risk of hemorrhage of melanoma brain metastases after Gamma Knife radiosurgery

S Hong, SM Bouchal, MMJ Bauman… - Journal of …, 2023 - thejns.org
OBJECTIVE The objective of this study was to analyze the hemorrhagic risk of melanoma
brain metastases after Gamma Knife radiosurgery (GKRS). METHODS A prospective …

Clinical significance of PDCD4 in melanoma by subcellular expression and in tumor-associated immune cells

TT Tran, CK Rane, CR Zito, SA Weiss, S Jessel… - Cancers, 2021 - mdpi.com
Simple Summary While targeting programmed cell death (PDCD) 1 is a central treatment
against melanoma, little is known about the related protein PDCD4. We defined differences …

Causality assessment between reported fatal cerebral haemorrhage and suspected drugs: developing a new algorithm based on the analysis of the Japanese …

M Ohta - European Journal of Clinical Pharmacology, 2021 - Springer
Purpose Cerebral haemorrhage is a life-threatening event with various causes including
adverse drug reactions (ADRs). Several methods have been proposed for the causality …

Immunotherapy Combined with Radiation in Malignant Melanoma without BRAF Mutations Brain Metastases—Favorable Response after Immunotherapy Continued …

RA Rahnea-Nita, LF Rebegea, RV Toma… - Journal of Personalized …, 2024 - mdpi.com
We present the case of a patient who was diagnosed in 2018 with nodular Malignant
Melanoma (MM) without BRAF V 600 mutations stage 3 C (pT4b pN1a M0), and who …

The value of anlotinib in the treatment of intractable brain edema: two case reports

S Yang, J Sun, M Xu, Y Wang, G Liu, A Jiang - Frontiers in Oncology, 2021 - frontiersin.org
About 20-30 percent of patients with cancer, such as non-small cell lung cancer, breast
cancer, melanoma and renal cell carcinoma, will develop brain metastases (BM). Primary …